138 related articles for article (PubMed ID: 30194939)
1. Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells.
Vitkeviciene A; Baksiene S; Borutinskaite V; Navakauskiene R
Eur J Pharmacol; 2018 Nov; 838():32-40. PubMed ID: 30194939
[TBL] [Abstract][Full Text] [Related]
2. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
Borutinskaitė V; Virkšaitė A; Gudelytė G; Navakauskienė R
Leuk Lymphoma; 2018 Feb; 59(2):469-478. PubMed ID: 28641467
[TBL] [Abstract][Full Text] [Related]
3. A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.
Jung JH; Yun M; Choo EJ; Kim SH; Jeong MS; Jung DB; Lee H; Kim EO; Kato N; Kim B; Srivastava SK; Kaihatsu K; Kim SH
Br J Pharmacol; 2015 Jul; 172(14):3565-78. PubMed ID: 25825203
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genes.
Goker B; Caliskan C; Onur Caglar H; Kayabasi C; Balci T; Erbaykent Tepedelen B; Aygunes D; Yilmaz Susluer S; Mutlu Z; Selvi Gunel N; Korkmaz M; Saydam G; Gunduz C; Biray Avci C
J BUON; 2014; 19(4):992-8. PubMed ID: 25536607
[TBL] [Abstract][Full Text] [Related]
5. Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells.
Huang Y; Zou Y; Lin L; Ma X; Huang X
Leuk Res; 2017 Nov; 62():34-39. PubMed ID: 28982057
[TBL] [Abstract][Full Text] [Related]
6. Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation.
Savickiene J; Treigyte G; Stirblyte I; Valiuliene G; Navakauskiene R
Leuk Res; 2014 Jul; 38(7):822-9. PubMed ID: 24832370
[TBL] [Abstract][Full Text] [Related]
7. 4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines.
Lompardía SL; Díaz M; Papademetrio DL; Pibuel M; Álvarez É; Hajos SE
Invest New Drugs; 2017 Feb; 35(1):1-10. PubMed ID: 27718039
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
Yao S; Zhong L; Chen M; Zhao Y; Li L; Liu L; Xu T; Xiao C; Gan L; Shan Z; Liu B
Int J Oncol; 2017 Sep; 51(3):899-906. PubMed ID: 28766684
[TBL] [Abstract][Full Text] [Related]
9. Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells.
Chen Y; Zhou Q; Zhang L; Wang R; Jin M; Qiu Y; Kong D
Oncol Rep; 2016 Dec; 36(6):3643-3650. PubMed ID: 27748929
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Berletch JB; Liu C; Love WK; Andrews LG; Katiyar SK; Tollefsbol TO
J Cell Biochem; 2008 Feb; 103(2):509-19. PubMed ID: 17570133
[TBL] [Abstract][Full Text] [Related]
11. [Effects of EGCG on Proliferation, Cell Cycle and DAPK1 Gene Methylation of Acute Promyelocytic Leukemia NB4 Cell Line].
Shi X; Gao HY; Yan W; He XW; Yang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1288-1293. PubMed ID: 30295240
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K/Akt/mTOR pathway and induces senescent cell death by regulation of Bax/Bcl-2 pathway.
Kumar R; Sharma A; Kumari A; Gulati A; Padwad Y; Sharma R
Biogerontology; 2019 Apr; 20(2):171-189. PubMed ID: 30456590
[TBL] [Abstract][Full Text] [Related]
13. [Epigallocatechin gallate induces
Wu M; Jiang M; Xue M; Li Q; Cheng B; Huang M; Xu L; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1230-1238. PubMed ID: 32990229
[TBL] [Abstract][Full Text] [Related]
14. [Effect of (-)-epigallocatechin-3-gallate and 5-AZA-CdR on expression of X-linked inhibitor of apoptosis protein-associated factor 1 in human leukemia HL-60 and K562 cells].
Huang YY; Xia Y; Guo HX; Li WY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):204-8. PubMed ID: 18250043
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RARα and HDAC1.
Moradzadeh M; Roustazadeh A; Tabarraei A; Erfanian S; Sahebkar A
Phytother Res; 2018 Mar; 32(3):471-479. PubMed ID: 29193405
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
Zhang JH; He YL; Zhu R; Du W; Xiao JH
Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
[TBL] [Abstract][Full Text] [Related]
19. Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.
Kim DS; Na YJ; Kang MH; Yoon SY; Choi CW
Korean J Intern Med; 2016 Mar; 31(2):357-66. PubMed ID: 26874514
[TBL] [Abstract][Full Text] [Related]
20. Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia.
Iwasaki R; Ito K; Ishida T; Hamanoue M; Adachi S; Watanabe T; Sato Y
Cancer Sci; 2009 Feb; 100(2):349-56. PubMed ID: 19200260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]